Cost-effectiveness analysis of recombinant activated factor VII as adjunctive therapy for bleeding control in severely injured trauma patients in Germany

Lignende værker

• Recombinant activated factor VII as an adjunctive therapy for bleeding control in severe trauma patients with coagulopathy: subgroup analysis from two randomized trials
  af: Rizoli, Sandro B, et al.
  Udgivet: (2006)
• Pharmacokinetics of recombinant activated factor VII in trauma patients with severe bleeding
  af: Klitgaard, Thomas, et al.
  Udgivet: (2006)
• A randomised, placebo-controlled, double-blind study to investigate the efficacy and safety of rFVIIa as adjunctive therapy for control of bleeding in patients with severe blunt trauma: a re-analysis following the exclusion of early (< 48 hours) deaths
  af: Rossaint, R, et al.
  Udgivet: (2005)
• Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding – a European perspective
  af: Vincent, Jean-Louis, et al.
  Udgivet: (2006)
• Numbers of Severely Injured Patients in Germany: A Retrospective Analysis From the DGU (German Society for Trauma Surgery) Trauma Registry
  af: Debus, Florian, et al.
  Udgivet: (2015)